KALARIS THERAPEUTICS, INC. (KLRS) Free cash flow 2019–2025
KALARIS THERAPEUTICS, INC. (KLRS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$38.6MFY2025 · since FY2019: -$20.5M → -$38.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.6M | — |
| FY2021 | -$106.3M | -74.2% |
| FY2020 | -$61.0M | -197.9% |
| FY2019 | -$20.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice